[Drug delivery to the brain with nanoparticles]
- PMID: 12962052
[Drug delivery to the brain with nanoparticles]
Abstract
Drugs can be delivered to brain with the aid of poly(butylcyanoacrylate) (PBCA) nanoparticles coated with polysorbate 80. These carriers can penetrate BBB and deliver drugs of various structures, including peptides, hydrophilic compounds, and lipophilic compounds eliminated from brain with P-glycoprotein. When a suspension of polysorbate-coated PBCA nanoparticles is introduced into blood, apolipoproteins of the blood plasma adsorb on the particle surface and then interact with receptors of low-density lipoproteins situated in endothelial cells of cerebral vessels, thus stimulating endocytosis.
Similar articles
-
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.Eur J Pharm Biopharm. 2008 Sep;70(1):75-84. doi: 10.1016/j.ejpb.2008.03.009. Epub 2008 Mar 27. Eur J Pharm Biopharm. 2008. PMID: 18472255
-
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.J Drug Target. 2009 Sep;17(8):564-74. doi: 10.1080/10611860903112842. J Drug Target. 2009. PMID: 19694610
-
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.Brain Res. 2008 Mar 20;1200:159-68. doi: 10.1016/j.brainres.2008.01.039. Epub 2008 Jan 26. Brain Res. 2008. PMID: 18291351
-
Polymeric nanoparticles for the drug delivery to the central nervous system.Expert Opin Drug Deliv. 2008 Feb;5(2):155-74. doi: 10.1517/17425247.5.2.155. Expert Opin Drug Deliv. 2008. PMID: 18248316 Review.
-
The role of peptides in blood-brain barrier nanotechnology.J Pept Sci. 2008 Feb;14(2):163-73. doi: 10.1002/psc.983. J Pept Sci. 2008. PMID: 18085720 Review.
Cited by
-
Enhanced brain penetration of hexamethonium in complexes with derivatives of fullerene C60.Dokl Biochem Biophys. 2016 May;468(1):173-5. doi: 10.1134/S1607672916030030. Epub 2016 Jul 15. Dokl Biochem Biophys. 2016. PMID: 27417712
-
Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.Adv Pharm Bull. 2016 Sep;6(3):319-335. doi: 10.15171/apb.2016.044. Epub 2016 Sep 25. Adv Pharm Bull. 2016. PMID: 27766216 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical